Strengthening of the Alliance on Actonel between the Sanofi-aventis Group and Procter & Gamble
Paris, October 8, 2004 Strengthening of the Alliance on Actonelâ between the Sanofi-aventis Group and Procter & Gamble The Sanofi-aventis Group and Procter & Gamble (P&G) announced that they have signed today an agreement to maintain the collaboration on Actonelâ (risedronate sodium tablets). Sanofi-aventis and P&G believe that this agreement will enhance the global market presence of Actonelâ. The alliance will continue to promote bone health and disease awareness through numerous activities to support physicians and patients. A common commitment has been formalized covering research and